April 12, 2024
Antimicrobial Catheter Market

Antimicrobial Catheter Market is Estimated to Witness High Growth Owing to Rising Prevalence of Hospital-Acquired Infections

Catheters placed into the urinary tract are prone to microbial colonization on the catheter surfaces, leading to biofilm formation which increases catheter-associated urinary tract infections (CAUTI). Antimicrobial catheters coated with antimicrobial agents help reduce microbial colonization and prevent biofilm formation, thereby lowering the risk of infections.

The Global Antimicrobial Catheter Market Size is estimated to be valued at US$ 14505.18 Mn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the antimicrobial catheter market are Pendulum, Amsterdam Winclove Probiotics, Metabogen AB (Biogaia), Exeliom Biosciences, TargEDys, Chr. Hansen Holding A/S, YSOPIA Bioscience, A-Mansia Biotech, Next Gen Probiotics, Evolve Biosystems and DuPont de Nemours, Inc. The key players are focusing on new product launches and collaborations to strengthen their market position. Innovation and technological advancements are expected to create lucrative growth opportunities in the market. The rising prevalence of hospital-acquired infections across developed as well as developing regions is driving the global expansion of the antimicrobial catheter market.

Key opportunities in the market include development of advanced infection control products to address the unmet needs. Growing healthcare infrastructure and patient awareness about consequences of catheter-associated infections in developing regions also present growth prospects. With rising geriatric population worldwide, long-term care facilities are increasingly adopting antimicrobial catheters to prevent infections among patients.

Market drivers: Rising prevalence of hospital-acquired infections is a key driver for the antimicrobial catheter market. According to the Centers for Disease Control and Prevention, around 750,000 cases of hospital-acquired infections occur in the US each year resulting in around 75,000 deaths. Catheter-associated urinary tract infections are one of the most common types of hospital-acquired infections. Antimicrobial catheters help combat antimicrobial resistance and reduce healthcare costs associated with treatment of infections.

PEST Analysis
Political: The key regulations regarding antimicrobial catheters are handled by regulatory bodies like the FDA in the US and EMA in Europe. Their stringent approval procedures ensure high quality and safety standards are met.

Economic: Rising healthcare costs globally are driving demand for products that can help reduce catheter-associated infections and lower hospitalization times and costs. Growth in disposable income also improves access to better medical care.

Social: With rising awareness about hospital-acquired infections, there is higher social acceptance and demand for technologies that enhance patient safety and recovery like antimicrobial catheters. An aging global population also fuels market growth.

Technological: Major players are focusing on developing novel technologies like silver alloy coatings, antibiotics coatings and gels, and probiotic coatings to make catheters more effective in preventing infections without promoting antimicrobial resistance. Some are also working on making catheters more comfortable for patients.

The geographical regions where the antimicrobial catheter market is most concentrated in terms of value are North America and Europe. This can be attributed to sophisticated healthcare infrastructure and higher healthcare spending per capita in these regions. However, the Asia Pacific region is expected to see the fastest growth in the market during the forecast period owing to expanding medical tourism industry, growing medical device demand and improving access to quality healthcare in developing countries like India and China.

In North America, the United States represents the largest market for antimicrobial catheters given the large pool of patients, advanced hospitals and frequent catheterizations. Europe is another major revenue generator led by countries like Germany, France and the UK with their strong economies and universal healthcare.

1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it